ANAPHYLACTIC SHOCK— THE OLD AND THE NEW IN THE TACTICS OF TREATMENT
https://doi.org/10.24884/2072-6716-2017-18-2-45-49
Abstract
Allergy is an adverse immune system reaction to a particular allergen. In recent years there has been an increase in the number of allergic diseases, the most severe of which is anaphylactic shock. Our review reflects the international experience of the strategy of treating anaphylactic shock and is aimed at determining the correct tactics of managing a patient with this severe pathology.
About the Authors
T. P. Bulach
North-Western State Medical University named after I. I. Mechnikov
Russian Federation
St. Petersburg
Russian Federation
St. Petersburg
V. E. Marusanov
North-Western State Medical University named after I. I. Mechnikov
Russian Federation
St. Petersburg
Russian Federation
St. Petersburg
V. A. Semkichev
North-Western State Medical University named after I. I. Mechnikov
Russian Federation
St. Petersburg
Russian Federation
St. Petersburg
References
1. Ковальчук Е.Ю. Клинические рекомендации (протокол) по оказанию скорой медицинской помощи при анафилактическом шоке. РОСМП, от 23 января 2014, г. Казань. Femb.ru. 2014. [Kovalchuk E. Yu. Klinicheskie rekomendacii (protokol) po okazaniyu skoroj medicinskoj pomoshhi pri anafilakticheskom shoke. ROSMP, ot 23 yanvarya 2014, g. Kazan. Femb.ru. 2014. (In Russ.)].
2. Commins S.P. Outpatient Emergencies: Anaphylaxis. Med Clin North, 2017, Vol. 101 (3), pp. 521–536. doi: 10.1016/j.mcna.2016.12.003.
3. Korosec P., Turner P.J., Silar M. et al. Basophils. high-affinity IgE receptors and CCL2 in human anaphylaxis. J. Allergy Clin. Immunol., 2017, Mar. 22, pii: S0091–6749(17)30423–2. doi: 10.1016/j.jaci.2016.12.989.
4. Cmorej P.C., Nesvadba M. et al. Management of acute anaphylaxis in clinical practice in the context of the guidelines. Epidemiol Miсrobiol Imunol., 2017, Vol. 66 (1), рр. 30–38.
5. Harper N. J., Dixon T., Dugué P. et al. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia, 2009, Vol. 64 (2), рр. 199–211. doi: 10.1111/j.
6. Tang M.L., Mullins R.J.. Food allergy: is prevalence increasing? Intern Med. J., 2017, Vol. 47 (3), рр. 256–261. doi: 10.1111/imj.13362.
7. Yanagida N., Sato S., Asaumi T. et al. Risk Factors for Severe Reactions during Double-Blind Placebo-Controlled Food Challenges. Int. Arch. Allergy Immunol., 2017, Vol. 172 (3), рр. 173–182. doi: 10.1159/000458724.
8. Gikas A., Lazaros G., Kontou-Fili K. Acute ST-segment elevation myocardial infarction after amoxycillininduced anaphylactic shock in a young adult with normal coronary arteries: a case report. BMC Cardiovasc Disord., 2005, Vol. 5 (1), рр. 6.
9. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin. North Am., 2006, Vol. 26 (3), рр. 451–463.
10. Sheikh A., Shehata Y.A., Brown S.G. et al. Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev. 2008, Vol. 4, рр. CD006312. doi: 10.1002/14651858.CD006312.pub2.
11. Campbell R.L., Bellolio M.F., Knutson B.D. et al. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J. Allergy Clin. Immunol. Pract., 2015, Vol. 3 (1), рр. 76–80. doi: 10.1016
12. Simons F.E., Simons K. J. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J. Allergy Clin. Immunol., 2001, Vol. 108 (5), рр. 871–873.
13. Singletary E.M., Charlton N.P., Epstein J.L. et al. Part 15: First Aid 2015 American Heart Association and American Red Cross Guidelines Update for First Aid. Circulation, 2015, Nov. 3, рр. 574–589. doi: 10.1161/CIR.0000000000000269.
14. Brasted I. D., Dailey M.W. Basic Life Support Access to Injectable Epinephrine across the United States. Prehosp. Emerg. Care, 2017, Vol. 24, рр. 1–6. doi: 10.1080/10903127.2017.1294224.
15. Schummer C., Wirsing M., Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg., 2008, Vol. 107 (2). рр. 620–624. doi: 10.1213
16. Thomas M., Crawford I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg. Med. J., 2005, Vol. 22 (4), рр. 272–273. doi: 10.1136/emj.2005.023507.
17. Sheikh A., Ten Broek V., Brown S. G., Simons F.E. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy, 2007, Vol. 62 (8), рр. 830–837.
18. Choo K.J., Simons F.E., Sheikh A. Glucocorticoids for the treatment of anaphylaxis. Evid. Based Child Health, 2013, Vol. 8 (4), рр. 1276–1294. doi: 10.1002/ebch.1925.
Review
For citations:
Bulach T.P., Marusanov V.E., Semkichev V.A. ANAPHYLACTIC SHOCK— THE OLD AND THE NEW IN THE TACTICS OF TREATMENT. EMERGENCY MEDICAL CARE. 2017;18(2):45-49. (In Russ.) https://doi.org/10.24884/2072-6716-2017-18-2-45-49
Views:
1301
Email this article 